Alcohol use disorder (AUD) affects between 4% and 6% of French adults, and requires appropriate medical treatment. However, 20-40% of patients with AUD are lost to follow-up at an early stage. Consequently, it is important for addiction departments to implement and evaluate innovative tools and interventions, including the involvement of peer support, to help patients remain in care, and to assess whether peer support has a positive impact on their clinical outcome. Addiction peer support specialists (APSSs) are individuals who have personally experienced addiction, and who have decided to use their experience to assist other people going through a similar situation, after completing a specific official graduation. Compared to other caregivers, APSSs may induce in patients a sense of identification which could improve the patient motivation to engage and remain in care. This is the main hypothesis and the main scientific objective of the PEERSIAD study, which will aim to confirm that accompanying patients with AUD using APSSs after alcohol detoxification, reduces the rate of lost-to-follow-up and improves the overall clinical outcome.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
626
Quality life questionnaire AQoLS will be completed by patients of both arms at inclusion, three and six months after inclusion
Quality life questionnaire Euroqol EQ-5D-5L will be completed by patients of both arms at inclusion, three and six months after inclusion
For patients included in the Peer support group, eight mandatory consultations with a peer support specialist will be performed between the inclusion visit and during the three following months. Patients can request additional consultations with the peer support specialist during the 6 first months of follow-up
CH Le Vinatier
Bron, France
Hôpital Beaujon
Clichy, France
GH Nord, Hospices Civils de Lyon
Lyon, France
CHS St Anne
Paris, France
Bichat Hospital
Paris, France
Unplanned cessation of care at 6 months
The unplanned cessation of care at 6 months, excluding consultations with an APSS, with no further contact in the following month, is defined as having had a last planned consultation that was not fulfilled between M0 and M6
Time frame: At 6 months after inclusion
Number of unfulfilled consultations
The number of unfulfilled consultations (scheduled consultations, excluding Peer Support consultations, without patient's visit with or without justification) over the 6-month study follow-up period, collected from the medical records of the addictology department.
Time frame: 6 months after inclusion
Euroqol-5D-5L questionnaire score
The differential cost-utility ratio, in relation to the innovative strategy including a Peer Support, will be assessed using the Euroqol-5D-5L questionnaire (EQ-5D-5L).
Time frame: At inclusion, 3 and 6 months after inclusion
Difference in costs (in euros)
An additional analysis will be carried out if the cost-utility ratio is positive: Difference in costs (in euros) for the payer (French compulsory health insurance) between a scenario in which the innovative management is implemented and disseminated in practice and on French territory, and a scenario in which usual follow-up is maintained.
Time frame: At 1, 2 and 3 years after the beginning of implementation on French territory
Number of AUD criteria according to Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
Time frame: At inclusion, 3 and 6 months after inclusion
Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) score
Time frame: At inclusion, 3 and 6 months after inclusion
average number of standard drinks declared per week
Time frame: At inclusion, 3 and 6 months after inclusion
Alcohol Quality of Life Scale (AQoLS) score
Changes in quality of life will be measured using the AQoLS
Time frame: At inclusion, 3 and 6 months after inclusion
State-Trait Anxiety Inventory (STAI-Y) score
Changes in levels of anxiety will be measured using STAI-Y
Time frame: At inclusion, 3 and 6 months after inclusion
Montgomery-Åsberg Depression Rating Scale (MADRS) score
Changes in levels of depression will be measured using MADRS
Time frame: At inclusion, 3 and 6 months after inclusion
Cannabis Use Disorders Identification Test - Revised (CUDIT-R) score
Changes in the severity of cannabis use will be measured by the CUDIT-R score
Time frame: At inclusion, 3 and 6 months after inclusion
type of opioid use
Time frame: At inclusion, 3 and 6 months after inclusion
frequency of opioid use
Time frame: At inclusion, 3 and 6 months after inclusion
type of psychostimulant use
Time frame: At inclusion, 3 and 6 months after inclusion
frequency of psychostimulant use
Time frame: At inclusion, 3 and 6 months after inclusion
Fagerström test score
Tobacco use will be measured by the Fagerström test
Time frame: At inclusion, 3 and 6 months after inclusion
Health Care Satisfaction Questionnaire (HCSQ) score
Patient's satisfaction will be measured by HCSQ questionnaire
Time frame: At 6 months after inclusion
Number of hospitalisations
Measurement of the number of hospitalisations related or not to the AUD and the ratio of total hospital days to number of hospital admissions (based on medical records and patient interviews)
Time frame: At 6 months after inclusion
Service organization description
Time frame: Before setting up of the study
Description of type of support and missions performed by Peer Support
Time frame: After last visit of last patient (around 3,5 years after first inclusion)
Acceptability of Intervention Measure (AIM) score
AIM score measured in Peer Support and medical staff
Time frame: After last visit of last patient (around 3,5 years after first inclusion)
AIM score
AIM score measured in patients
Time frame: At 6 months after inclusion
Adoption of intervention
adoption of intervention will be assessed through semi-structured interviews and measurement of the number of patients followed-up versus the number of eligible patients, refusals to be accompanied by APSS, and premature discontinuation of follow-up
Time frame: After last visit of last patient (around 3,5 years after first inclusion)
Intervention fidelity
intervention fidelity will be assessed by monitoring APSS activity indicators, describing deviations from the protocol and semi-structured interviews
Time frame: After last visit of last patient (around 3,5 years after first inclusion)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.